Vigano'D'Angelo S, Gugliotta L, Mattioli Belmonte M, Cascione M L, Pattarini E, D'Angelo A
Servizio di Coagulazione, IRCCS H.S.Raffaele, Milano, Italy.
Thromb Res. 1990 Sep 15;59(6):985-94. doi: 10.1016/0049-3848(90)90122-s.
The changes in plasma levels of the vitamin K-dependent natural anticoagulants protein C (PC) and protein S (PS) and procoagulant factors II, IX and X were evaluated in 8 adult patients during treatment with L-asparaginase (L-ase i.v. 120,000 U/m2 over 10 days). PC anticoagulant activity and factor IX, X and II coagulant activity decreased proportionally to their half-lives to a nadir of 50-60% of pretreatment values after 2-5 L-ase infusions, suggesting that inhibition of protein synthesis rather than consumption is the main mechanism responsible for the observed changes. Free PS antigen levels declined at a rate similar to total PS antigen, reaching a nadir of 56% of pretreatment values after 3 L-ase infusions; however due to C4b-binding protein levels higher than total PS levels (p less than 0.05), they were constantly lower than the corresponding total PS antigen levels (0.05 less than p less than 0.001). This implicates that total PS antigen levels cannot be taken as an indicator of PS activity. No differences between the antigenic levels and the anticoagulant activities of PC and free PS could be observed suggesting that L-ase does not affect the mechanisms of vitamin K-dependent carboxylation of Gla-residues. The faster rate of decline of PC and PS activities relative to that of factor II may be responsible for the onset of an hypercoagulable state during the early phase of L-ase treatment.
在8例成年患者接受L-天冬酰胺酶治疗(静脉注射L-天冬酰胺酶120,000 U/m²,持续10天)期间,评估了维生素K依赖性天然抗凝蛋白C(PC)和蛋白S(PS)以及促凝血因子II、IX和X的血浆水平变化。PC抗凝活性以及因子IX、X和II的凝血活性与其半衰期成比例下降,在2 - 5次L-天冬酰胺酶输注后降至预处理值的50 - 60%的最低点,这表明蛋白质合成受抑制而非消耗是导致观察到的变化的主要机制。游离PS抗原水平以与总PS抗原相似的速率下降,在3次L-天冬酰胺酶输注后降至预处理值的56%的最低点;然而,由于C4b结合蛋白水平高于总PS水平(p < 0.05),它们一直低于相应的总PS抗原水平(0.05 < p < 0.001)。这意味着总PS抗原水平不能作为PS活性的指标。未观察到PC和游离PS的抗原水平与抗凝活性之间存在差异,表明L-天冬酰胺酶不影响维生素K依赖性γ-羧基谷氨酸残基的羧化机制。PC和PS活性相对于因子II的下降速度更快,可能是L-天冬酰胺酶治疗早期高凝状态发生的原因。